Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent progress in sepsis epidemiology--have we learned enough?

Herwig Gerlach1, Didier Keh

  • 1Department of Anesthesiology and Critical Care Medicine, Vivantes-Klinikum Neukoelln, Berlin, Germany. herwig.gerlach@knk-berlin.de

Critical Care (London, England)
|September 17, 2003
PubMed
Summary

Despite advances in sepsis treatment, clinical practice varies widely. Ongoing surveillance and education are crucial for improving care for severe sepsis and septic shock patients in intensive care units worldwide.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Summary of the update to the S3 guideline: Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia].

Pneumologie (Stuttgart, Germany)·2025
Same author

[S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2025
Same author

Corticosteroids for treating sepsis in children and adults.

The Cochrane database of systematic reviews·2025
Same author

[Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia].

Pneumologie (Stuttgart, Germany)·2025
Same author

Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007.

Infection·2024
Same author

Patient-Level Meta-Analysis of Low-Dose Hydrocortisone in Adults with Septic Shock.

NEJM evidence·2024

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases Epidemiology

Background:

  • Severe sepsis and septic shock remain significant challenges in intensive care units (ICUs).
  • Global epidemiological studies are essential for understanding disease burden and trends.
  • Network-based systems have improved ICU morbidity and mortality assessment.

Purpose of the Study:

  • To analyze the current epidemiology of sepsis and infection in ICU patients globally.
  • To assess the variability in treatment strategies for septic patients.
  • To highlight the gap between evaluated treatment strategies and routine clinical practice.

Main Methods:

  • Utilized data from the Sepsis Occurrence in the Acutely Ill Patient (SOAP) study.
  • Analyzed global data on sepsis and infection in ICU settings.

Related Experiment Videos

  • Examined treatment variations among septic patients.

    • Main Results:

    • Significant variations in the treatment of septic patients were observed.
    • Even evidence-based sepsis treatment strategies are not consistently implemented in routine ICU care.
    • Epidemiological data underscore the need for continued global surveillance.

    Conclusions:

    • Current sepsis treatment protocols show considerable variability in practice.
    • Further attention to surveillance and education is vital for improving sepsis management.
    • Bridging the gap between research findings and clinical implementation is critical for better patient outcomes in severe sepsis and septic shock.